By 2025, Pfizer plans to submit new drug marketing applications for approximately 12 innovative drugs in China, covering multiple therapeutic areas including oncology, vaccines, anti-infectives, inflammation, and immunology. (China News Service)
Pfizer Plans to Submit Applications for Approximately 12 Innovative Drugs in China by 2025
Feb 16, 2023 17:57
CST Updated
17:57
Pfizer
Pharmaceutical R&D Developer